I suspect $68 is Johnson & Johnson's best offer ? they don't have much room to go higher.

Nike will be a share gainer in the U.S.. Their U.S. business has been excellent. The area most people are concerned about is Europe.

What drives this business now is pricing its products correctly and making the right assumptions on costs. They also are entering into areas that will be more growth driven in the future.

Eighty dollars is a 'wow' number ? I don't think there's any way J&J can rationally compete with that.

There's a good chance this will come down to the shareholders.

There's nothing too provocative here ? most of it makes sense.